{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:42:07Z","timestamp":1770752527948,"version":"3.50.0"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":1806,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To compare misoprostol with standard oxytocic regimens in the prevention of postpartum haemorrhage.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Randomised controlled trial.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Obstetric unit in a large teaching hospital.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> One thousand women randomised to 500 \u03bcg misoprostol given orally or to standard oxytocic regimens of oxytocin, oxytocin with ergometrine, or ergometrine.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Incidence of postpartum haemorrhage and the incidence and severity of side effects.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Postpartum haemorrhage occurred in 12% of women given misoprostol and in 11% of women given standard oxytocic drugs (relative risk (RR) 1.10, 95% confidence interval (CI) 0.79, 1.55). Blood loss of 1000 mL or more occurred in 2% of women in each group. Nausea, headache, dizziness and tiredness were less frequent with misoprostol (RR (95% CI) 0.71 (0.59, 0.84); 0.53 (0.38, 0.74); 0.73 (0.61, 0.87) and 0.88 (0.83, 0.94) respectively). The main side effects of misoprostol were shivering (RR 1.95, 95% CI 1.69, 2.25) and a rise in temperature (difference in mean rise 0.34\u00b0C, 95% CI 0.26, 0.42).<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Oral misoprostol for the prevention of postpartum haemorrhage was comparable to standard oxytocics. Many side effects were less common with misoprostol but shivering and pyrexia were more common. Larger randomised trials are needed before establishing the equivalence between misoprostol and standard oxytocic drugs in the prevention of postpartum haemorrhage.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2000.tb11108.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:37:54Z","timestamp":1123843074000},"page":"1104-1110","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management"],"prefix":"10.1111","volume":"107","author":[{"given":"Hazem","family":"El\u2010Refaey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randa","family":"Nooh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Geary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Walder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Rodeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"107","volume-title":"Preventing Maternal Deaths","author":"World Health Organisation","year":"1989"},{"key":"e_1_2_5_3_2","first-page":"3","volume-title":"Maternal Mortality: A Global Factbook","author":"World Health Organisation","year":"1991"},{"key":"e_1_2_5_4_2","first-page":"20","volume-title":"findings and conclusions","author":"National maternal mortality study:","year":"1994"},{"key":"e_1_2_5_5_2","first-page":"1145","volume-title":"Effective Care in Pregnancy and Childbirth","author":"Prendiville W","year":"1989"},{"key":"e_1_2_5_6_2","first-page":"2974","volume-title":"Cochrane Database of Systematic Reviews. The Cochrane Collaboration","author":"Keirse MJNC","year":"1995"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6659.1295"},{"key":"e_1_2_5_8_2","first-page":"169","volume-title":"Obstetrics and the Newborn","author":"Beischer NA","year":"1986"},{"key":"e_1_2_5_9_2","volume-title":"Stability of Injectable Oxytocics in Tropical Climates","author":"Hogerzeil HV","year":"1993"},{"key":"e_1_2_5_10_2","volume-title":"ABPI Data Sheet Compendium","author":"Data sheet compendium","year":"1993"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610100202"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-0664-9_15"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600810209"},{"key":"e_1_2_5_14_2","first-page":"539","article-title":"Activite contragestivie de l'association au RU486 d'une prostaglandine active par voie'oral","volume":"312","author":"Aubeny E","year":"1991","journal-title":"CR Acad Sci III"},{"key":"e_1_2_5_15_2","first-page":"1744","article-title":"The abortifacient effect of misoprostol in the second trimester","volume":"8","author":"El\u2010Refaey H","year":"1993","journal-title":"Hum Reprod"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321502"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92406-6"},{"key":"e_1_2_5_18_2","first-page":"244","article-title":"Intravaginal misoprostol versus dinoprostone as cervical ripening and labour inducing agents","volume":"83","author":"Fletcher H","year":"1994","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(87)90047-5"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000010028"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(87)90048-7"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb11948.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90771-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11464.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00161-6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.1998.770209.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10259.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6913.1167"},{"key":"e_1_2_5_29_2","first-page":"83","article-title":"The Salford third stage trial: oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labour","volume":"2","author":"Mitchell GG","year":"1993","journal-title":"Online J Curr Clin Trials"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(95)80014-J"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.3109\/01443618109067375"},{"key":"e_1_2_5_32_2","first-page":"424","article-title":"A comparative study of different medical treatments of the third stage of labour","volume":"53","author":"Nieminen U","year":"1963","journal-title":"Ann Chir Gynaecol Fenn"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb11288.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0266-6138(05)80091-9"},{"key":"e_1_2_5_35_2","volume-title":"Prophylactic syntometrine vs oxytocin in the third stage of labour. The Cochrane Library","author":"McDonald S","year":"1998"},{"key":"e_1_2_5_36_2","volume-title":"Active versus expectant management of the third stage of labour. The Cochrane Library","author":"Prendiville WJ","year":"1998"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.2307\/2346945"},{"key":"e_1_2_5_38_2","first-page":"20","volume-title":"Report on Confidential Enquiries into Maternal Deaths in the United Kingdom","year":"1996"},{"key":"e_1_2_5_39_2","first-page":"712","article-title":"The obstetrical use of ergot","volume":"87","author":"Ringrose CAD","year":"1962","journal-title":"Can Med Assoc J."},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6920.59"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a135965"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016346609158459"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1995.tb04117.x"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7157.512"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2000.tb11108.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2000.tb11108.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:11:22Z","timestamp":1697415082000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2000.tb11108.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1111\/j.1471-0528.2000.tb11108.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb11108.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2005-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}